News And Posts

By Aviad Tamir

•  VR in Healthcare- The market for virtual reality / artificial intelligence healthcare tools is expected to surpass $34 billion by the mid-2020s, driven largely by a growing desire to automate tasks and gain deeper insights into clinical and financial issues. AI applications are designed to address specific, real-world use cases that make the diagnosis, monitoring, and treatment of patients more efficient, accurate, and available to populations around the world. Software developers can expect to see an $8.6 billion annual market by 2025, contributing to the $34 billion total in software sales, hardware installations, and consulting opportunities within the AI market.

• Wearable Biosensors- A wearable biosensor is an analytical device which is used to monitor vital signs of an individual person. It consists of three major components including a bioreactor system, transducer and output devices. Biosensors are used to monitor, record and transmit physiological signals in order to offer a better healthcare experience to the global population. Wearable Biosensors can be personalized to the specific needs of the patient and can assist with early diagnosis by detecting symptoms. They can assist patients to take their medication on time and additionally alert healthcare providers if the medication wasn't taken. The remote wearable devices save time and mobility, as healthcare providers can access information any time from any location without the patient leaving their homes. The Wearable Biosensors market is expected to exceed more than $27 billion by 2022 at a CAGR of 8% in the given forecast period.

• Biological Drugs are a rapidly growing field. They include any pharmaceutical drug product manufactured in, extracted from, or synthesized from biological sources. The assessment is that by the year 2023, a quarter of the drug market will consist of biological drugs. In addition to the expected growth of the field, we are seeing significant growth in the Biosimilar field (generifying biological drugs) in order to cut costs and make the drugs accessible to a wider market. The growth we see originates in the United States, where 25-35 new drugs are expected to enter the market by 2020 – and from Asia and China, which are at the frontier of development in the field.

• Personalized Medicine is an additional field that is growing and estimated to be worth $141 billion by 2026. The expected growth will be driven by the use of medical databases (both private and governmental initiatives to map out medical information), alongside tech advancements and use of advanced and effective technology for treatment plans and disease prevention. Israel is interested in looking into potential cooperation between key players in the health industry, with local industries and MNCs by researching electronic medical information to find groundbreaking solutions in the personalized medicine field.

• 3D Printing and Nanotechnology – The use of this tech in the health and life science world is one of the most intriguing trends for a number of reasons. Firstly, because of its ability to personalize treatment by printing cells and tissues. Secondly, the ability to use the technology to make production of existing products more efficient. Experts predict that by 2024, the market will be worth $2.2 billion. There are patients alive today with printed organs. Using nanotechnology, innovators are able to develop personalized white blood cells that can molecularly attack cancer cells.

• Additional fields that have investment potential in the life science ecosystem and are worth mentioning are Diabetes Therapy and the Drug Delivery Market. The market value is estimated to reach $9.6 billion by 2022. Another field worth mentioning is the Biosensors field, which is estimated to be worth $21 billion by 2020.